Carboxypeptidase G2 Antibody Conjugates as Anti-Tumor Agents
Author Information
Author(s): R.G. Melton, F. Searle, R.F. Sherwood, K.D. Bagshawe, J.A. Boden
Primary Institution: Division of Biotechnology, PHLS Centre for Applied Microbiology and Research; Department of Medical Oncology, Charing Cross Hospital
Hypothesis
Can carboxypeptidase G2 antibody conjugates effectively target and clear tumors in vivo?
Conclusion
F(ab')2: CPG2 conjugates localize effectively at tumor sites while minimizing uptake in normal tissues.
Supporting Evidence
- Conjugates of W14A-F(ab')2 fragment coupled to CPG2 localized in tumors as effectively as native antibody.
- Clearance rates of conjugates were up to five-fold faster than for native antibody.
- F(ab')2: CPG2 conjugates showed lower uptake in normal tissues compared to native W14A.
Takeaway
Scientists are trying to use special proteins to help medicine find and attack tumors better without hurting healthy parts of the body.
Methodology
The study involved injecting mice with radiolabeled antibody-enzyme conjugates and measuring their localization and clearance from tumors and other tissues.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
Male nude mice bearing CC3 choriocarcinoma xenografts.
Want to read the original?
Access the complete publication on the publisher's website